Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Rooshi Nathwani
Observed names:
Nathwani, Rooshi,
R Nathwani,
R. Nathwani
Institutions:
Imperial College Healthcare NHS Trust,
Royal Free London NHS Foundation Trust
Observed institutions:
Imperial College Healthcare NHS Trust,
Royal Free London NHS Foundation Trust,
London North West Healthcare NHS Trust,
Lister Hospital,
The Royal Free Hospital,
St Mary's Hospital,
Queen's Hospital,
St Mark's Hospital,
Imperial College London
show all 9
ORCID:
0000-0002-5069-7956
Observed ORCID:
0000-0002-5069-7956
OpenAlex ID:
A5006328275
Effect of COVID-19 lockdown on alcohol consumption in patients with pre-existing alcohol use disorder
2020
·
Jin Un Kim
, Amir Majid
, et al.
·
The Lancet. Gastroenterology & hepatology
·
224
PDF
CD14 + CD15 − HLA-DR − myeloid-derived suppressor cells impair antimicrobial responses in patients with acute-on-chronic liver failure
2017
·
Christine Bernsmeier
, Evangelos Triantafyllou
, et al.
·
Gut
·
176
PDF
CD8+ T cells from patients with cirrhosis display a phenotype that may contribute to cirrhosis-associated immune dysfunction
2019
·
Fanny Lebossé
, Cathrin Gudd
, et al.
·
EBioMedicine
·
110
PDF
Activation and transcriptional profile of monocytes and CD8+ T cells are altered in checkpoint inhibitor-related hepatitis
2021
·
Cathrin L.C. Gudd
, Lewis Au
, et al.
·
Journal of Hepatology
·
75
PDF
In-hospital mortality is associated with inflammatory response in NAFLD patients admitted for COVID-19
2020
·
Roberta Forlano
, Benjamin H. Mullish
, et al.
·
PLoS ONE
·
67
PDF
Current and future pharmacological therapies for managing cirrhosis and its complications
2019
·
David Kockerling
, Rooshi Nathwani
, et al.
·
World Journal of Gastroenterology
·
58
Non-Alcoholic Fatty Liver Disease and Vascular Disease
2020
·
Roberta Forlano
, Benjamin H. Mullish
, et al.
·
Current Vascular Pharmacology
·
24
A Review of Liver Fibrosis and Emerging Therapies
2020
·
Rooshi Nathwani
, Benjamin H. Mullish
, et al.
·
European Medical Journal
·
14
PDF
Suppressor CD4+T cells expressing HLA-G are expanded in the peripheral blood from patients with acute decompensation of cirrhosis
2021
·
Wafa Khamri
, Cathrin Gudd
, et al.
·
Gut
·
12
PDF
PTH-106 Plasma S100A8/A9: a novel mechanistic biomarker in innate immune activation in acute-on-chronic liver failure
2018
·
A Singanayagam
, R Nathwani
, et al.
·
Gut
·
5
PDF
Letter: liver disease and COVID‐19—not the perfect storm
2020
·
Rooshi Nathwani
, Sujit Mukherjee
, et al.
·
Alimentary Pharmacology & Therapeutics
·
3
PDF
Review of Rifaximin: A Summary of the Current Evidence and Benefits Beyond Licensed Use
2021
·
Rooshi Nathwani
, Benjamin Mullish
, et al.
·
European Medical Journal
·
2
PDF
Non-selective beta-blocker use in cirrhosis: the additional benefit in preventing secondary infections
2021
·
Rooshi Nathwani
, David Kockerling
, et al.
·
Frontline Gastroenterology
·
2
A complicated case of anticoagulation
2013
·
Rooshi Nathwani
·
BMJ Case Reports
·
2
PDF
PS-174-Serum bile acid profiles distinguish severe alcoholic hepatitis from decompensated alcohol-related cirrhosis
2019
·
Luke D. Tyson
, Stephen Atkinson
, et al.
·
Journal of Hepatology
·
1
THU-052-Immunometabolic profiling of ascites from patients with acute-on-chronic liver failure reveals increased MerTK+ immunosuppressive myeloid cells and cell death markers with preferential lipid metabolism compared to cirrhosis without organ failure
2019
·
Arjuna Singanayagam
, Davide Erminelli
, et al.
·
Journal of Hepatology
·
1
Pathogenesis, clinical evolution and outcomes of patients with immune checkpoint inhibitor induced acute liver injury: A multicentre study
2018
·
L. Au
, R. Nathwani
, et al.
·
Annals of Oncology
·
1
PWE-085 Immune checkpoint inhibitor induced acute liver injury – a national cohort study
2018
·
Rooshi Nathwani
, L Au
, et al.
·
Gut
·
1
PDF
Rifaximin to reduce infection in decompensated cirrhosis
2017
·
Rooshi Nathwani
·
http://isrctn.com/
·
1
P117 From risk identification to intervention: success of a community-based clinical nurse specialist–led MASLD model
2026
·
Alice Furness
, Megan Morgan
, et al.
·
Gut
PDF
FP29 Machine learning and generative artificial intelligence models outperform established prognostic scoring systems in predicting acute decompensation in patients with cirrhosist
2026
·
Mathew Vithayathil
, James Bell
, et al.
·
Gut
WED-530 Machine learning and generative artificial intelligence models outperform established prognostic scoring systems in predicting acute decompensation in patients with chronic liver disease
2026
·
Mathew Vithayathil
, James Bell
, et al.
·
Journal of Hepatology
P337 Is it time to relook at the ‘hub & spoke’ model for delivering hepatology care in the UK?
2025
·
Rooshi Nathwani
·
Gut
P344 Evaluating referrals to a UK tertiary hepatology and liver transplant centre
2025
·
Haziq Ibrahim
, Kohilan Gananandan
, et al.
·
Gut
Liver Decompensation and Acute on Chronic Liver Failure
2022
·
R. Nathwani
, N. Selvapatt
, et al.
·
In clinical practice
Show more works
View as search
Works count:
42
Citation count:
779
H-index:
9
I10-index:
9
Year
Topic
Type